|
End-of-day quote
Berne S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 135.88 CHF | -2.33% |
|
-1.13% | -6.19% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.13% | -2.31% | -0.47% | -3.12% | +7.43% | +39.88% | +114.49% | +402.89% | +1,325.41% | 1,031B | |
| -1.90% | -4.03% | -4.21% | +2.28% | +25.52% | +39.62% | +67.43% | +61.88% | +118.64% | 638B | |
| -0.40% | -1.78% | +0.15% | +3.72% | +13.96% | +6.55% | +75.64% | +138.69% | +311.81% | 462B | |
| -1.17% | -2.87% | -4.08% | +14.65% | +36.56% | +59.48% | +40.17% | +76.58% | +129.91% | 359B | |
| -0.03% | -3.96% | +0.43% | +6.14% | +6.34% | +23.63% | +40.70% | +1.09% | +44.39% | 335B | |
| -1.58% | -0.76% | -9.85% | -5.55% | +7.72% | +13.50% | +26.44% | +55.22% | +53.52% | 273B | |
| -2.02% | -2.97% | +0.59% | -13.15% | -12.75% | -3.25% | +9.88% | +37.15% | +138.68% | 253B | |
| -2.55% | +1.19% | -6.22% | +13.71% | +25.53% | +37.64% | +54.28% | +92.06% | +145.53% | 228B | |
| -1.01% | -1.28% | -1.43% | +17.31% | +20.39% | +32.95% | +99.42% | +115.53% | +89.38% | 185B | |
| -1.26% | -1.19% | -14.94% | -22.84% | -23.14% | -31.80% | -60.74% | -18.43% | +84.16% | 170B | |
| -1.28% | -0.90% | -1.38% | +17.90% | +13.07% | +3.47% | -17.04% | -34.42% | -16.40% | 163B | |
| -3.02% | -3.11% | -7.58% | +1.64% | +11.65% | +25.22% | +45.52% | +180.65% | +483.20% | 133B | |
| -1.48% | -0.20% | -8.29% | +8.74% | +13.78% | +29.40% | +6.09% | +3.13% | +12.29% | 127B | |
| +5.32% | +2.90% | -1.34% | +16.47% | +9.06% | +16.93% | +104.52% | +347.25% | +440.93% | 99.55B | |
| -2.02% | -4.37% | -4.09% | -6.99% | -1.62% | +7.39% | +20.96% | +3.64% | -13.75% | 97.46B | |
| +0.63% | +1.39% | -4.89% | +0.07% | -11.63% | -14.18% | -28.21% | -11.51% | +7.12% | 98.83B | |
| +0.03% | -1.86% | +23.94% | +163.72% | +548.36% | +592.75% | +85.07% | -43.94% | - | 76.88B | |
| -2.33% | -7.01% | -10.15% | +18.49% | -4.10% | +23.38% | -9.51% | +29.69% | +83.76% | 75.72B | |
| -2.64% | +0.37% | -3.79% | -6.96% | +9.67% | +11.62% | -12.98% | -26.53% | +39.40% | 68.18B | |
| Average | -1.02% | +0.05% | -3.03% | +11.91% | +36.62% | +48.12% | +34.85% | +74.24% | +193.22% | 256.48B | |
| Weighted average by Cap. | -1.01% | -0.14% | -2.81% | +4.84% | +20.05% | +34.39% | +55.99% | +135.48% | +391.38% |
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
